CONDENSED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS’ DEFICIT (Unaudited) - USD ($) $ in Thousands |
Total |
Series A Redeemable Convertible Preferred Stock |
Series B Redeemable Convertible Preferred Stock |
Series C Redeemable Convertible Preferred Stock |
Common Stock |
Additional Paid-In Capital |
Accumulated Deficit |
Beginning balance (in shares) at Dec. 31, 2019 |
|
8,350,743
|
46,176,715
|
0
|
|
|
|
Beginning balance at Dec. 31, 2019 |
|
$ 7,519
|
$ 66,186
|
$ 0
|
|
|
|
Increase (Decrease) in Temporary Equity [Roll Forward] |
|
|
|
|
|
|
|
Exercise of redeemable convertible preferred stock warrants (in shares) |
|
|
|
27,308,227
|
|
|
|
Exercise of redeemable convertible preferred stock warrants |
|
|
|
$ 96,963
|
|
|
|
Conversion of redeemable convertible preferred stock (in shares) |
|
|
|
1,690,380
|
|
|
|
Conversion of redeemable convertible preferred stock |
|
|
|
$ 6,182
|
|
|
|
Ending balance (in shares) at Sep. 30, 2020 |
|
8,350,743
|
46,176,715
|
28,998,607
|
|
|
|
Ending balance at Sep. 30, 2020 |
|
$ 7,519
|
$ 66,186
|
$ 103,145
|
|
|
|
Beginning balance (in shares) at Dec. 31, 2019 |
|
|
|
|
18,704,118
|
|
|
Beginning balance at Dec. 31, 2019 |
$ (58,139)
|
|
|
|
$ 0
|
$ 4,945
|
$ (63,084)
|
Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
Exercise of common stock options (in shares) |
|
|
|
|
1,918,499
|
|
|
Vesting of early exercised stock options |
729
|
|
|
|
|
729
|
|
Stock-based compensation |
242
|
|
|
|
|
242
|
|
Vesting of restricted stock and issuance of common stock per restricted stock purchase agreements (in shares) |
|
|
|
|
7,373,163
|
|
|
Net income (loss) |
(27,816)
|
|
|
|
|
|
(27,816)
|
Ending balance (in shares) at Sep. 30, 2020 |
|
|
|
|
27,995,780
|
|
|
Ending balance at Sep. 30, 2020 |
(84,984)
|
|
|
|
$ 0
|
5,916
|
(90,900)
|
Beginning balance (in shares) at Dec. 31, 2019 |
|
8,350,743
|
46,176,715
|
0
|
|
|
|
Beginning balance at Dec. 31, 2019 |
|
$ 7,519
|
$ 66,186
|
$ 0
|
|
|
|
Ending balance (in shares) at Dec. 31, 2020 |
|
8,350,743
|
46,176,715
|
28,998,607
|
|
|
|
Ending balance at Dec. 31, 2020 |
176,323
|
$ 7,519
|
$ 66,186
|
$ 102,618
|
|
|
|
Beginning balance (in shares) at Dec. 31, 2019 |
|
|
|
|
18,704,118
|
|
|
Beginning balance at Dec. 31, 2019 |
(58,139)
|
|
|
|
$ 0
|
4,945
|
(63,084)
|
Ending balance (in shares) at Dec. 31, 2020 |
|
|
|
|
27,995,780
|
|
|
Ending balance at Dec. 31, 2020 |
(101,400)
|
|
|
|
$ 0
|
9,036
|
(110,436)
|
Beginning balance (in shares) at Jun. 30, 2020 |
|
8,350,743
|
46,176,715
|
28,998,607
|
|
|
|
Beginning balance at Jun. 30, 2020 |
|
$ 7,519
|
$ 66,186
|
$ 103,145
|
|
|
|
Ending balance (in shares) at Sep. 30, 2020 |
|
8,350,743
|
46,176,715
|
28,998,607
|
|
|
|
Ending balance at Sep. 30, 2020 |
|
$ 7,519
|
$ 66,186
|
$ 103,145
|
|
|
|
Beginning balance (in shares) at Jun. 30, 2020 |
|
|
|
|
20,224,118
|
|
|
Beginning balance at Jun. 30, 2020 |
(76,591)
|
|
|
|
$ 0
|
5,771
|
(82,362)
|
Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
Exercise of common stock options (in shares) |
|
|
|
|
398,499
|
|
|
Stock-based compensation |
145
|
|
|
|
|
145
|
|
Vesting of restricted stock and issuance of common stock per restricted stock purchase agreements (in shares) |
|
|
|
|
7,373,163
|
|
|
Net income (loss) |
(8,538)
|
|
|
|
|
|
(8,538)
|
Ending balance (in shares) at Sep. 30, 2020 |
|
|
|
|
27,995,780
|
|
|
Ending balance at Sep. 30, 2020 |
(84,984)
|
|
|
|
$ 0
|
5,916
|
(90,900)
|
Beginning balance (in shares) at Dec. 31, 2020 |
|
8,350,743
|
46,176,715
|
28,998,607
|
|
|
|
Beginning balance at Dec. 31, 2020 |
176,323
|
$ 7,519
|
$ 66,186
|
$ 102,618
|
|
|
|
Increase (Decrease) in Temporary Equity [Roll Forward] |
|
|
|
|
|
|
|
Exercise of redeemable convertible preferred stock warrants (in shares) |
|
48,513
|
31,369
|
|
|
|
|
Exercise of redeemable convertible preferred stock warrants |
|
$ 831
|
$ 537
|
|
|
|
|
Conversion of redeemable convertible preferred stock (in shares) |
|
(8,399,256)
|
(46,208,084)
|
(28,998,607)
|
|
|
|
Conversion of redeemable convertible preferred stock |
|
$ (8,350)
|
$ (66,723)
|
$ (102,618)
|
|
|
|
Ending balance (in shares) at Sep. 30, 2021 |
|
0
|
0
|
0
|
|
|
|
Ending balance at Sep. 30, 2021 |
0
|
$ 0
|
$ 0
|
$ 0
|
|
|
|
Beginning balance (in shares) at Dec. 31, 2020 |
|
|
|
|
27,995,780
|
|
|
Beginning balance at Dec. 31, 2020 |
(101,400)
|
|
|
|
$ 0
|
9,036
|
(110,436)
|
Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
Conversion of redeemable convertible preferred stock (in shares) |
|
|
|
|
83,605,947
|
|
|
Conversion of redeemable convertible preferred stock |
177,691
|
|
|
|
$ 1
|
177,690
|
|
Conversion of convertible notes into common stock (in shares) |
|
|
|
|
18,611,914
|
|
|
Conversion of convertible notes into common stock |
$ 297,792
|
|
|
|
|
297,792
|
|
Exercise of common stock options (in shares) |
1,698,265
|
|
|
|
1,485,282
|
|
|
Exercise of common stock options |
$ 417
|
|
|
|
|
417
|
|
Stock-based compensation expense from issuance of a fully vested warrant to vendor |
1,239
|
|
|
|
|
1,239
|
|
Issuance of common stock at public offering, net of issuance costs (in shares) |
|
|
|
|
14,375,000
|
|
|
Issuance of common stock at public offering, net of issuance costs |
205,293
|
|
|
|
|
205,293
|
|
Exercise of common stock warrants (in shares) |
|
|
|
|
84,118
|
|
|
Exercise of common stock warrants |
77
|
|
|
|
|
77
|
|
Vesting of early exercised stock options |
109
|
|
|
|
|
109
|
|
Tax withholding on exercise of stock options and restricted stock units |
(4,586)
|
|
|
|
|
(4,586)
|
|
Common stock issued to outgoing directors (in shares) |
|
|
|
|
128,000
|
|
|
Stock-based compensation |
25,558
|
|
|
|
|
25,558
|
|
Vesting of restricted stock and issuance of common stock per restricted stock purchase agreements (in shares) |
|
|
|
|
76,557
|
|
|
Net income (loss) |
52,188
|
|
|
|
|
|
52,188
|
Ending balance (in shares) at Sep. 30, 2021 |
|
|
|
|
146,362,598
|
|
|
Ending balance at Sep. 30, 2021 |
654,378
|
|
|
|
$ 1
|
712,625
|
(58,248)
|
Beginning balance (in shares) at Jun. 30, 2021 |
|
8,350,743
|
46,176,715
|
28,998,607
|
|
|
|
Beginning balance at Jun. 30, 2021 |
|
$ 7,519
|
$ 66,186
|
$ 102,618
|
|
|
|
Increase (Decrease) in Temporary Equity [Roll Forward] |
|
|
|
|
|
|
|
Exercise of redeemable convertible preferred stock warrants (in shares) |
|
48,513
|
31,369
|
|
|
|
|
Exercise of redeemable convertible preferred stock warrants |
|
$ 831
|
$ 537
|
|
|
|
|
Conversion of redeemable convertible preferred stock (in shares) |
|
(8,399,256)
|
(46,208,084)
|
(28,998,607)
|
|
|
|
Conversion of redeemable convertible preferred stock |
|
$ (8,350)
|
$ (66,723)
|
$ (102,618)
|
|
|
|
Ending balance (in shares) at Sep. 30, 2021 |
|
0
|
0
|
0
|
|
|
|
Ending balance at Sep. 30, 2021 |
0
|
$ 0
|
$ 0
|
$ 0
|
|
|
|
Beginning balance (in shares) at Jun. 30, 2021 |
|
|
|
|
29,128,604
|
|
|
Beginning balance at Jun. 30, 2021 |
(61,332)
|
|
|
|
$ 0
|
16,264
|
(77,596)
|
Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
Conversion of redeemable convertible preferred stock (in shares) |
|
|
|
|
83,605,947
|
|
|
Conversion of redeemable convertible preferred stock |
177,691
|
|
|
|
$ 1
|
177,690
|
|
Conversion of convertible notes into common stock (in shares) |
|
|
|
|
18,611,914
|
|
|
Conversion of convertible notes into common stock |
297,792
|
|
|
|
|
297,792
|
|
Exercise of common stock options (in shares) |
|
|
|
|
436,576
|
|
|
Exercise of common stock options |
159
|
|
|
|
|
159
|
|
Issuance of common stock at public offering, net of issuance costs (in shares) |
|
|
|
|
14,375,000
|
|
|
Issuance of common stock at public offering, net of issuance costs |
205,293
|
|
|
|
|
205,293
|
|
Vesting of early exercised stock options |
46
|
|
|
|
|
46
|
|
Tax withholding on exercise of stock options and restricted stock units |
(4,586)
|
|
|
|
|
(4,586)
|
|
Common stock issued to outgoing directors (in shares) |
|
|
|
|
128,000
|
|
|
Stock-based compensation |
19,967
|
|
|
|
|
19,967
|
|
Vesting of restricted stock and issuance of common stock per restricted stock purchase agreements (in shares) |
|
|
|
|
76,557
|
|
|
Net income (loss) |
19,348
|
|
|
|
|
|
19,348
|
Ending balance (in shares) at Sep. 30, 2021 |
|
|
|
|
146,362,598
|
|
|
Ending balance at Sep. 30, 2021 |
$ 654,378
|
|
|
|
$ 1
|
$ 712,625
|
$ (58,248)
|